A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
Year: 2006
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Actelion Pharmaceuticals
OpenAlex ID: W1985669197
